3BX7

engineered human lipocalin 2 (lcn2) in complex with the extracellular domain of human ctla-4

• Total interactions analyzed: 1
• Total true interactions: 1
• Strongest Interaction:
  • Chains: C-A
  • Int. Res.: 115
  • Norm. En. per Res.: -3.3617
• Hub Node: C(1)

All Interactions

Chains	Hydro. Bond Ener. (kJ/mol)	Elec. Ener. (kJ/mol)	VDW. Ener. (kJ/mol)	Tot. Stab. Ener. (kJ/mol)	#int. res.	# Short cont.	#Hydr. int.	#VDW pairs	#salt bridges	#Pot. fav. elec. int	#Pot. unfav. elec. int
C-A	-46.6446	-59.8798	-280.074	-386.5983	115	13	7	11891	5	20	20

Interface residues

• C-A: ALA126A, ALA130A, ALA134A, ALA26C, ALA31C, ALA37A, ALA51C, ALA53A, ALA6C, ALA81A, ARG35C, ARG40A, ARG40C, ARG43A, ASN110C, ASN129A, ASN164A, ASN39A, ASN50A, ASN96A, ASP128A, ASP44A, GLN45C, GLN46A, GLU127A, GLU131A, GLU33C, GLU48C, GLU77A, GLU97C, GLY107C, GLY109C, GLY111C, GLY29C, GLY38A, GLY95A, HIS165A, HIS47A, HIS4C, HIS73A, ILE108C, ILE135A, ILE166A, ILE41A, ILE70A, ILE80A, ILE93C, ILE97A, LEU106C, LEU107A, LEU125A, LEU36A, LEU39C, LEU42A, LEU7A, LEU94A, LEU98C, LYS103A, LYS124A, LYS30C, LYS74A, LYS75A, LYS95C, MET3C, MET49A, MET51A, MET55C, MET56C, MET99C, PHE122A, PHE123A, PHE132A, PHE133A, PHE83A, PRO101C, PRO102C, PRO103C, PRO169A, PRO28C, PRO48A, SER105A, SER27C, SER68A, SER71A, SER72A, SER99A, THR104A, THR136A, THR32C, THR37C, THR47C, THR54A, THR67A, THR79A, THR82A, TYR100A, TYR100C, TYR104C, TYR105C, TYR106A, TYR138A, TYR25C, TYR52A, TYR56A, TYR78A, VAL108A, VAL121A, VAL167A, VAL33A, VAL34C, VAL46C, VAL49C, VAL5C, VAL66A, VAL69A